Splicing modifier created to treat SMA because of mutations in chromosome 5q that lead to survival motor neuron (SMN) protein deficiency. Evrysdi is administered every day at home in liquid variety by mouth or by feeding tube. Risdiplam (Evrysdi®) is the first oral drug made to deal with spinal muscular https://cornstalks641ims4.tusblogos.com/profile